Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

[1]  D. Yardley.  Taxanes in the elderly patient with metastatic breast cancer , 2015, Breast cancer.

[2]  T. Dimpfl,et al.  The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up. , 2015, Deutsches Arzteblatt international.

[3]  M. Blettner,et al.  Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients , 2015, Archives of Gynecology and Obstetrics.

[4]  H. Cohen,et al.  Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance). , 2014, Journal of oncology practice.

[5]  E. Messing,et al.  Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview. , 2012, Urologic oncology.

[6]  H. Cohen,et al.  Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  L. Ngo,et al.  Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Stram,et al.  Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort , 2010, Breast Cancer Research.

[9]  M. Zauderer,et al.  Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer , 2009, Breast Cancer Research and Treatment.

[10]  Elena M. Buzaianu,et al.  Predictors of Toxicity and Toxicity Profile of Adjuvant Chemotherapy in Elderly Breast Cancer Patients , 2009, The breast journal.

[11]  G. Vlastos,et al.  Older female cancer patients: importance, causes, and consequences of undertreatment. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Sandbank,et al.  Breast cancer in the elderly: histological, hormonal and surgical characteristics. , 2007, Breast.

[13]  J. Lovato,et al.  Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting. , 2006, Critical reviews in oncology/hematology.

[14]  R. Gelber,et al.  Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  S. Monfardini,et al.  Adjuvant chemotherapy for elderly patients (> or =70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  C. Shapiro,et al.  Older women with breast carcinoma are less likely to receive adjuvant chemotherapy , 2003, Cancer.

[17]  Joy H. Lewis,et al.  Participation of patients 65 years of age or older in cancer clinical trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  G. Hortobagyi,et al.  Breast conservation therapy as a treatment option for the elderly , 2001, Cancer.

[19]  R Yancik,et al.  Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. , 2001, JAMA.

[20]  R. Elledge,et al.  Tumor characteristics and clinical outcome of elderly women with breast cancer. , 2000, Journal of the National Cancer Institute.

[21]  G. Lyman,et al.  Comorbidity and functional status are independent in older cancer patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[23]  D. Tripathy.  Adjuvant chemotherapy in Older Women with Early-Stage Breast Cancer , 2010 .

[24]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.